VISTEON CORP
For the period ended Sep 30, 2026. Filed Oct 22, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 22, 2026
VC$80.39+3.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine Months Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Operating Activities | ||
| Net income (loss) | $89 | $135 |
| Adjustments to reconcile net income (loss) to net cash provided from (used by) operating activities: | ||
| Depreciation and amortization | 89 | 80 |
| Non-cash stock-based compensation | 35 | 34 |
| Equity in net loss (income) of non-consolidated affiliates, net of dividends remitted | (8) | (5) |
| Tax valuation allowance expense (benefit) | — | 61 |
| Other non-cash items | 2 | (3) |
| Changes in assets and liabilities: | ||
| Accounts receivable | (91) | 43 |
| Inventories | (94) | (13) |
| Accounts payable | 86 | 6 |
| Other assets and other liabilities | (27) | (46) |
| Net cash provided from operating activities | 81 | 292 |
| Investing Activities | ||
| Capital expenditures, including intangibles | (103) | (88) |
| Acquisition of business, net of cash acquired | (20) | (50) |
| Net investment hedge transactions | (11) | 3 |
| Other | — | (1) |
| Net cash used by investing activities | (134) | (136) |
| Financing Activities | ||
| Borrowings from term debt facility | 2 | — |
| Principal repayment of term debt facility | (7) | (13) |
| Borrowings from revolving credit facility | 179 | — |
| Repayment of revolving credit facility | (153) | — |
| Other short-term debt, net | 8 | — |
| Dividends to shareholders | (29) | (8) |
| Dividends to non-controlling interests | (9) | (20) |
| Repurchase of common stock | (236) | (7) |
| Stock-based compensation tax withholding payments | (9) | (7) |
| Proceeds from the exercise of stock options | 8 | 3 |
| Contingent consideration payments | (13) | — |
| Other | (2) | — |
| Net cash used by financing activities | (261) | (52) |
| Effect of exchange rate changes on cash | 7 | 35 |
| Net increase (decrease) in cash, equivalents, and restricted cash | (307) | 139 |
| Cash, equivalents, and restricted cash at beginning of the period | 773 | 626 |
| Cash, equivalents, and restricted cash at end of the period | $466 | $765 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.